Mumbai UK-based CDC Group has committed $10 million to Chiratae Ventures’ Fund IV, which focuses on highly scalable, tech-enabled companies, as it seeks to increase its presence in India’s tech startup ecosystem.
“CDC’s commitment to Chiratae Ventures’ Fund IV is a show of confidence in India’s innovative ecosystem,” said Sudhir Sethi, founder and chairman, Chiratae Ventures.
The fund will focus primarily on early-stage investments with the flexibility to invest at seed and expansion stages, backing companies in deep-tech, consumer media, software, fintech and health tech.
Chiratae has so far backed Cure.Fit, FirstCry, Bounce, Lenskart and PolicyBazaar to name a few.
